Efficient DNA Condensation Induced by Ruthenium(II) Complexes of a Bipyridine‐Functionalized Molecular Clip Ligand

Complexes of the type [Ru(bxbg)₂(N‐N)]²⁺, where N‐N denotes 2,2′‐bipyridine (bpy) ( 1 ), 1,10‐phenanthroline (phen) ( 2 ), dipyrido[3,2‐d:2′,3‐f] quinoxaline (dpq) ( 3 ), and dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) ( 4 ), incorporating bis(o‐xylene)bipyridine‐glycoluril (bxbg) as an ancillary “molecular clip” ligand, have been synthesized and characterized. These ruthenium(II) complexes of bis(o‐xylene)bipyridine‐glycoluril self‐associate in water through specific molecular recognition processes to form polycationic arrays. These arrays containing electrostatic binders as well as intercalator ligands at micromolar doses rapidly condense free DNA into globular nanoparticles of various sizes. The DNA condensation induced by these complexes has been investigated by electrophoretic mobility assay, dynamic light scattering, and transmission electron microscopy. The cellular uptake of complex–DNA condensates and the low cytotoxicity of these complexes satisfy the requirements of a gene vector.     

Synthesis,crystal structures,DNA/bovine serum albumin binding,DNA cleavage and cytotoxicity of five mononuclear zinc(II) complexes

Five new mononuclear zinc(II) complexes containing ligands with extended planar phenanthroline moieties (dipyrido‐[3,2‐a:2′,3′‐c]phenazine (dppz) or dipyrido[3,2‐d:2′,3′‐f] quinoxaline (dpq)), namely [Zn(dppz)(acac)₂]⋅CH₃OH ( 1 ), [Zn(dppz)(dbm)(OAc)] ( 2 ), [Zn(dpq)(dbm) (OAc)] 1.5H₂O ( 3 ), [Zn(dpq)(tfnb)(OAc)] ( 4 ) and [Zn(dpq)(tfnb)₂] ( 5 ), where acac = acetylacetonate, tfnb = benzoyltrifluoroacetone and dbm = dibenzoylmethane, were synthesized and structurally characterized. The binding ability of complexes 1 – 5 with calf thymus DNA was investigated by spectroscopic titration methods and viscosity measurements. Results indicate that all complexes bind to calf thymus DNA via intercalative mode, and the DNA binding affinities of dppz complexes 1 and 2 are apparently stronger than those of dpq complexes 3 – 5 . DNA photocleavage experiments reveal that these complexes are efficient DNA cleaving agents and they are more active in UV‐A (365 nm) than in visible light. In particular, the in vitro cytotoxicity of the complexes for human cancer cell line A549 demonstrates that the five compounds have anticancer activity with low IC₅₀ values. Meanwhile, interaction of the complexes with bovine serum albumin investigated using UV–visible and fluorescence methods indicates that all complexes can quench the intrinsic fluorescence of bovine serum albumin in a static quenching process.     

DNA Interactions of the Functionalized (Mixed Polypyridine)ruthenium(II) Complex Bis(2,2′‐bipyridine‐κN1,κN1′)(methyl dipyrido[3,2‐a : 2′,3′‐c]phenazine‐11‐carboxylate‐κN4,κN5)ruthenium(2+) ([Ru(bpy)2(dppz‐11‐CO2Me)]2+)

A novel polypyridine ligand, dipyrido[3,2‐a:2′,3′‐c]phenazine‐11‐carboxylic acid methyl ester (=dppz‐11‐CO₂Me), and its ruthenium(II) complex, [Ru(bpy)₂(dppz‐11‐CO₂Me)]²⁺ ( 1 ), were synthesized and characterized. The binding properties of this complex to calf‐thymus DNA (CT‐DNA) were investigated by different spectrophotometric methods and viscosity measurements. The results suggest that the complex binds to DNA in an intercalative mode and serves as a molecular ‘light switch’ for DNA. When irradiated at 365 nm, the complex 1 promoted the photocleavage of plasmid pBR‐322 DNA.     

A one‐dimensional nickel(II) coordination polymer containing 2,6‐dipicolinate and dipyrido[3,2‐a:2′,3′‐c]phenazine

A new coordination polymer, catena‐poly[[(dipyrido[3,2‐a:2′,3′‐c]phenazine‐κ²N,N′)nickel(II)]‐μ‐2,6‐dipicolinato‐κ⁴O²,N,O⁶:O^2′], [Ni(C₇H₃NO₄)(C₁₈H₁₀N₄)]_n, exhibits a one‐dimensional structure in which 2,6‐dipicolinate acts as a bridging ligand interconnecting adjacent nickel(II) centers to form a chain structure. The asymmetric unit contains one Ni^II center, one dipyrido[3,2‐a:2′,3′‐c]phenazine ligand and one 2,6‐dipicolinate ligand. Each Ni^II center is six‐coordinated and surrounded by three N atoms and three O atoms from one dipyrido[3,2‐a:2′,3′‐c]phenazine ligand and two different 2,6‐dipicolinate ligands, leading to a distorted octahedral geometry. Adjacent chains are linked by π–π stacking interactions and weak interactions to form a three‐dimensional supramolecular network.     

Synthesis,crystal structures,DNA binding and cleavage properties and protein binding activities of three mononuclear cobalt(II) complexes

Three new mononuclear cobalt(II) complexes containing ligands with extended planar quinoxaline moieties, {dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) or dipyrido[3,2‐d:2′,3′‐f]quinoxaline (dpq)}, viz. [Co(dppz)(acac)₂] · CH₃OH ( 1 ), [Co(dpq)(tfnb)₂] ( 2 ) and [Co(dpq)(dbm)₂] ( 3 ), where acac = acetylacetonate, tfnb = benzoyltrifluoroacetone and dbm = dibenzoylmethane, have been synthesized and structurally characterized as octahedral complexes. The binding ability of the complexes with calf thymus (CT)‐DNA has been investigated by spectroscopic and viscosity measurements. Results indicate that all complexes bind to CT‐DNA via intercalative mode, and the DNA binding affinity of dppz complex 1 is apparently stronger than that of dpq complexes 2 and 3 . Furthermore, DNA photocleavage experiments indicate that these complexes are efficient DNA cleaving agents in UV‐A (365 nm) and hydroxyl radical (HO^·), singlet oxygen (¹O₂) and superoxide anion (¹O₂^?) serve as the major cleavage active species. In addition, interaction of the complexes with bovine serum albumin (BSA) was investigated using UV ? visible and fluorescence methods, which indicated that all complexes could quench the intrinsic fluorescence of BSA in a static quenching process. Copyright © 2014 John Wiley & Sons, Ltd.     

Synthesis,DNA-binding,and photocleavage properties of Ru(II) complexes containing dppz-based ligand

A ligand ipdp (ipdp?=?indeno[1′,2′?:?5,6]pyrazino[2,3-i]dipyrido[3,2-a?:?2′,3′-c]phenazine-8-one) and its ruthenium complexes, [Ru(L)₂(ipdp)]²⁺ (L?=?bpy (2,2′-bipyridine), phen (1,10-phenanthroline)), have been synthesized and characterized by elemental analysis, electrospray mass spectra, and ¹H NMR. The interaction between the complexes and calf thymus DNA (CT-DNA) has been investigated by spectroscopic methods and viscosity measurements. The results indicate that the complexes can bind to CT-DNA in an intercalative mode. In addition, both complexes promote the photocleavage of plasmid pBR322 DNA under irradiation. The mechanistic studies reveal that singlet oxygen ¹O₂ plays a significant role in DNA photocleavage.     

Visible‐Light‐Driven Hydrogen Production and Polymerization using Triarylboron‐Functionalized Iridium(III) Complexes

The development of novel iridium(III) complexes has continued as an important area of research owing to their highly tunable photophysical properties and versatile applications. In this report, three heteroleptic dimesitylboron‐containing iridium(III) complexes, [Ir(p‐B‐ppy)₂(N^N)]⁺ {p‐B‐ppy=2‐(4‐dimesitylborylphenyl)pyridine; N^N=dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) ( 1 ), dipyrido[3,2‐d:2′,3′‐f]quinoxaline (dpq) ( 2 ), and 1,10‐phenanthroline (phen) ( 3 )}, were prepared and fully characterized electrochemically, photophysically, and computationally. Altering the conjugated length of the N^N ligands allowed us to tailor the photophysical properties of these complexes, especially their luminescence wavelength, which could be adjusted from λ=583 to 631 nm in CH₂Cl₂. All three complexes were evaluated as visible‐light‐absorbing sensitizers for the photogeneration of hydrogen from water and as photocatalysts for the photopolymerization of methyl methacrylate. The results showed that all of them were active in both photochemical reactions. High activity for the photosensitizer (over 1158 turnover numbers with 1 ) was observed, and the system generated hydrogen even after 20 h. Additionally, poly(methyl methacrylate) with a relatively narrow molecular‐weight distribution was obtained if an initiator (i.e., ethyl α‐bromophenylacetate) was used. The living character of the photoinduced polymerization was confirmed on the basis of successful chain‐extension experiments.     

Mitochondria‐Targeting Oxidovanadium(IV) Complex as a Near‐IR Light Photocytotoxic Agent

Oxidovanadium(IV) complexes [VO(L¹)(phen)] ? Cl ( 1 ) and [VO(L²)(L³)] ? Cl ( 2 ), in which HL¹ is 2‐{[(benzimidazol‐2‐yl)methylimino]‐methyl}phenol (sal‐ambmz), HL² is 2‐[({1‐[(anthracen‐9‐yl)methyl]‐benzimidazol‐2‐yl}methylimino)‐methyl]phenol (sal‐an‐ambmz), phen is 1,10‐phenanthroline and L³ is dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) conjugated to a Gly‐Gly‐OMe dipeptide moiety, were prepared, characterized, and their DNA binding, photoinduced DNA‐cleavage, and photocytotoxic properties were studied. Fluorescence microscopy studies were performed by using complex 2 in HeLa and HaCaT cells. Complex 1 , structurally characterized by X‐ray crystallography, has a vanadyl group in VO₂N₄ core with the VO²⁺ moiety bonded to N,N‐donor phen and a N,N,O‐donor Schiff base. Complex 2 , having an anthracenyl fluorophore, showed fluorescence emission bands at 397, 419, and 443 nm. The complexes are redox‐active exhibiting the V(IV)/V(III) redox couple near ?0.85 V versus SCE in DMF 0.1 M tetrabutylammonium perchlorate (TBAP). Complex 2 , having a dipeptide moiety, showed specific binding towards poly(dAdT)₂ sequence. The dppz‐Gly‐Gly‐OMe complex showed significant DNA photocleavage activity in red light of 705 nm through a hydroxyl radical (^.OH) pathway. Complex 2 showed photocytotoxicity in HaCaT and HeLa cells in visible light (400–700 nm) and red light (620–700 nm), however, the complex was less toxic in the dark. Fluorescence microscopy revealed the localization of complex 2 primarily in mitochondria. Apoptosis was found to occur inside mitochondria (intrinsic pathway) caused by ROS generation.     

Ruthenium(II)–arene complexes of diimines: Effect of diimine intercalation and hydrophobicity on DNA and protein binding and cytotoxicity

A series of half‐sandwich Ru(II)–arene complexes [Ru(η⁶‐benzene)(diimine)Cl](PF₆) ( 1 – 4 ), where diimine is 1,10‐phenanthroline ( 1 ), 5,6‐dimethyl‐1,10‐phenanthroline ( 2 ), dipyrido[3,2‐a:2′,3′‐c]phenazine ( 3 ) or 11,12‐dimethyldipyrido[3,2‐a:2′,3′‐c]phenazine ( 4 ), have been isolated and characterized using analytical and spectral methods. Complex 2 possesses a familiar pseudo‐octahedral ‘piano‐stool’ structure. The intrinsic DNA binding affinity of the complexes depends upon the diimine ligand: 3 (dppz) > 4 (11,12‐dmdppz) > 2 (5,6‐dmp) > 1 (phen). The π‐stacking interaction of extended planar ring of coordinated dppz ( 3 ) in between the DNA base pairs is more intimate than that of phen ( 1 ), and the incorporation of methyl groups on the dppz ring ( 4 ) discourages the stacking interaction leading to a lower DNA binding affinity for 4 than 3 . Docking studies show that all the complexes bind in the major groove of DNA. Interestingly, 3 shows an ability to convert supercoiled DNA into nicked circular DNA even at 20 μM concentration beyond which complete oxidative DNA degradation is observed. The protein binding affinity of the complexes decreases in the order 4 > 3 > 2 > 1 , and the higher protein binding affinity of 4 illustrates the strong involvement of methyl groups on dppz ring in hydrophobic interaction with protein. Also, 4 cleaves protein more efficiently than the other complexes in the presence of H₂O₂. It is notable that 2 , 3 and 4 display cytotoxicity against human cervical cancer cell lines (SiHa) with potency higher than the currently used drug cisplatin. Acridine orange/ethidium bromide staining studies reveal that 3 induces apoptosis in cancer cells much more efficiently than 4 .     

Design and spectroscopic study of new ruthenium(II) complexes containing ligands derived from terpyridine and dipyrido[3,2‐a:2′,3′‐c]phenazine: {Ru(4′‐Rph‐tpy) [dppz(COOH)]Cl}PF6 with R = NO2, Br,Cl

A series of polypyridine ruthenium complexes of the general formula {Ru(Rph‐tpy)[dppz(COOH)]Cl} PF₆ with R = Br ( 1 ), Cl ( 2 ), NO₂ ( 3 ) where Rph‐tpy is 4′‐(4‐Rphenyl‐2,2′:6′,2″‐terpyridine and dppz(COOH) is dipyrido[3,2‐a:2′,3′‐c]phenazine‐2‐carboxylic acid were prepared and characterized. These complexes display intense metal‐to‐ligand charge‐transfer (MLCT) bands centered about 500 nm. The effect of pH on the absorption spectra of these complexes consisting of protonatable ligands has been investigated in water solution by spectrophotometric titration. The electrochemistry shows oxidation potentials for the Ru(II)–Ru(III) couple at +0.881 ( 1 ), +0.907 ( 2 ) and +0.447 V ( 3 ), respectively. Copyright © 2006 John Wiley & Sons, Ltd.     

Synthesis of ruthenium complexes with carbonyl and polypyridyl ligands derived from dipyrido[3,2‐a:2′,3′‐c]phenazine: application to the water gas shift reaction

The preparation and spectroscopic properties of new dipyrido[3,2‐a:2′,3′‐c]phenazine ruthenium complexes are described. The complexes show high catalytic activity in the water gas shift reaction in a basic medium under mild conditions (P_CO = 0.9 atm at 100 °C). Copyright © 2002 John Wiley & Sons, Ltd.     

Structure of the Complex of [Ru(tpm)(dppz)py]2+ with a B‐DNA Oligonucleotide—A Single‐Substituent Binding Switch for a Metallo‐Intercalator

We report the synthesis of three new complexes related to the achiral [Ru(tpm)(dppz)py]²⁺ cation (tpm=tripyridazole methane, dppz=dipyrido[3,2‐a:2′,3′‐c]phenazine, py=pyridine) that contain an additional single functional group on the monodentate ancillary pyridyl ligand. Computational calculations indicate that the coordinated pyridyl rings are in a fixed orientation parallel to the dppz axis, and that the electrostatic properties of the complexes are very similar. DNA binding studies on the new complexes reveal that the nature and positioning of the functional group has a profound effect on the binding mode and affinity of these complexes. To explore the molecular and structural basis of these effects, circular dichroism and NMR studies on [Ru(tpm)(dppz)py]Cl₂ with the octanucleotides d(AGAGCTCT)₂ and d(CGAGCTCG)₂, were carried out. These studies demonstrate that the dppz ligand intercalates into the G²–A³ step, with {Ru(tpm)py} in the minor groove. They also reveal that the complex intercalates into the binding site in two possible orientations with the pyridyl ligand of the major conformer making close contact with terminal base pairs. We conclude that substitution at the 2‐ or 3‐position of the pyridine ring has little effect on binding, but that substitution at the 4‐position drastically disrupts intercalative binding, particularly with a 4‐amino substituent, because of steric and electronic interactions with the DNA. These results indicate that complexes derived from these systems have the potential to function as sequence‐specific light‐switch systems.     

A Synthetic,Structural, Spectroscopic and DFT study of ReI,CuI, RuII and IrIII Complexes Containing Functionalised Dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz)

The ligands 11‐cyanodipyrido[3,2‐a:2′,3′‐c]phenazine and 2‐(11‐dipyrido[3,2‐a:2′,3′‐c]phenazine)‐5‐phenyl‐1,3,4‐oxadiazole have been coordinated to Re^I, Cu^I, Ru^II and Ir^III metal centres. Single‐crystal X‐ray analyses were performed on fac‐chlorotricarbonyl(11‐cyanodipyrido[3,2‐a:2′,3′‐c]phenazine)rhenium (C₂₂H₉ClN₅O₃Re, a=6.509(5), b=12.403(5), c=13.907(5) Å, α=96.88(5), β=92.41(5), γ=92.13(5)°, triclinic, P , Z=2) and bis‐2,2′‐bipyridyl(2‐(11‐dipyrido[3,2‐a:2′,3′‐c]phenazine)‐5‐phenyl‐1,3,4‐oxadiazole)ruthenium triflate ? 2 CH₃CN (C₅₂H₃₆F₆N₁₂O₈RuS₂, a=10.601(5), b=12.420(5), c=20.066(5) Å, α=92.846(5), β=96.493(5), γ=103.720(5)°, triclinic, P , Z=2). The ground‐ and excited‐state properties of the ligands and complexes have been investigated with a range of techniques, including electrochemistry, absorption and emission spectroscopy, spectroelectrochemistry and excited‐state lifetime studies. Spectroscopic, time‐resolved and DFT studies reveal that the ligand‐centred (LC) transitions and their resultant excited states play an important role in the photophysical properties of the complexes. Evidence for the presence of lower‐lying metal‐to‐ligand charge‐transfer transitions is obtained from resonance Raman spectroscopy, but nanosecond transient Raman experiments suggest that once excited, the ³LC state is populated.     

Molecular modeling of the binding mode of chiral metal complexes δ- and ∧-[Co(phen)2dppz]3+with B-DNA

Molecular modeling methods have been applied to the structural characterization of the interaction between chiral metal complexes [Co(phen)₂dppz]³⁺ (where phen = 1, 10-phenanthroline, dppz = dipyrido[3,2-a: 2′, 3′ -c]phenazine) and the oligonucleotide (B-DNA fragment). The natures of two kinds of the binding modes, which are currently intense controversy, have been explored. Barton proposed that there is enantio-selective DNA binding by the octahedral complexes and intercalative access by these complexes from the major groove; but Norden suggested that both enantiomers bind extremely strongly to DNA from the minor groove without any noticeable enantio-selectivity. Our results support and extend structural models based upon Norden’s studies, and conflict with Barton’ model.     

A one‐dimensional chain structure based on unusual tetranuclear manganese(II) clusters

The title coordination polymer, poly[bis(μ₄‐biphenyl‐2,2′‐dicarboxylato)(dipyrido[3,2‐a:2′,3′‐c]phenazine)manganese(II)], [Mn₂(C₁₄H₈O₄)₂(C₁₈H₁₀N₄)]_n, was obtained through the reaction of MnCl₂·4H₂O, biphenyl‐2,2′‐dicarboxylic acid (H₂dpdc) and dipyrido[3,2‐a:2′,3′‐c]phenazine (L) under hydrothermal conditions. The asymmetric unit contains two crystallographically unique Mn^II ions, one unique L ligand and two unique dpdc ligands. One Mn ion is six‐coordinated by four O atoms from three different dpdc ligands and two N atoms from one L ligand, adopting a distorted octahedral coordination geometry. The distortions from ideal octahedral geometry are largely due to the presence of chelating ligands and the resulting acute N—Mn—N and O—Mn—O angles. The second Mn ion is coordinated in a distorted trigonal bipyramidal fashion by five O atoms from four distinct dpdc ligands. Four Mn^II ions are bridged by the carboxylate groups of the dpdc ligands to form an unusual tetranuclear Mn^II cluster. Clusters are further connected by the aromatic backbone of the dicarboxylate ligands, forming a one‐dimensional chain structure along the b axis. The title compound is the first example of a chain structure based on a tetranuclear Mn^II cluster.     

Polycyclic N‐Heterocyclic Compounds. Part 84: Reaction of N‐(pyrido[3′,2′:4,5]thieno[3,2‐d]pyrimidin‐4‐yl)amidines or N‐(pyrido[2′,3′:4,5]furo[3,2‐d]pyrimidin‐4‐yl)amidines with Hydroxylamine Hydrochloride

The reactions of nine N‐(pyrido[3′,2′:4,5]thieno[3,2‐d]pyrimidin‐4‐yl)amidines ( 3 ) with hydroxylamine hydrochloride produced new cyclization products. These were formed via ring cleavage of the pyrimidine component followed by a 1,2,4‐oxadiazole‐forming ring closure to give N‐[2‐([1,2,4]oxadiazol‐5‐yl)thieno[2,3‐b]pyridin‐3‐yl]formamide oximes ( 11 ). Reaction of six N‐(pyrido[2′,3′:4,5]furo[3,2‐d]pyrimidin‐4‐yl)amidines ( 12 ) with hydroxylamine hydrochloride gave similar results. Effects of the newly synthesized compounds on pentosidine formation were also evaluated.     

Synthesis and Characterization of Polypiridine‐Based Rhenium(I) Complexes with Pyrazino[2,3‐f][1,10]phenanthroline

A series of tricarbonyl rhenium(I) complexes of the type fac‐[Re^I(CO)₃(ppl)(L)]^0/+, where ppl is pyrazino[2,3‐f][1,10]phenanthroline, and where L is Cl^?, TfO^?, 4‐(tert‐butyl)pyridine (^tBu‐py), 4‐methoxypyridine (MeO‐py), 4,4′‐bipyridyl (bpy), or 10‐(picolin‐4‐yl)phenothiazine (pptz), were synthesized and fully characterized. In all complexes, an increment in the electron‐acceptor properties of ppl compared to the free ligand was observed. This effect was more significant for pyridine‐type ligands, especially for pptz, compared to Cl^? or TfO^?. The properties of fac‐[Re(CO)₃(ppl)(pptz)]PF₆ were compared with those of the analogous compound fac‐[Re(CO)₃(dppz)(pptz)]PF₆, where dppz is dipyrido(3,2‐a : 2′,3′‐c)phenazine, the goal being to generate long‐lived excited charge‐transfer (CT) states. In this respect, fac‐[Re(CO)₃(ppl)(pptz)]PF₆ seems to be a promising candidate.     

Synthesis,characterization, and evaluation of biological activities of new 4′‐substituted ruthenium (II) terpyridine complexes: Prospective anti‐inflammatory properties

The synthesis and characterization of Ru (II) terpyridine complexes derived from 4′ functionalized 2,2′:6′,2″‐terpyridine (tpy) ligands are reported. The heteroleptic complexes comprise the synthesized ligands 4′‐(2‐thienyl)‐ 2,2′:6′,2″‐terpyridine) or (4′‐(3,4‐dimethoxyphenyl)‐2,2′:6′,2″‐terpyridine and (dimethyl 5‐(pyrimidin‐5‐yl)isophthalate). The new complexes [Ru(4′‐(2‐thienyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)Cl₂] ( 9 ), [Ru(4′‐(3,4‐dimethoxyphenyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)Cl₂] ( 10 ), and [Ru(4′‐(2‐thienyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)(NCS)₂] ( 11 ) were characterized by ¹H‐ and ¹³C‐NMR spectroscopy, C, H, N, and S elemental analysis, UPLC‐ESI‐MS, TGA, FT‐IR, and UV‐Vis spectroscopy. The biological activities of the synthesized ligands and their Ru (II) complexes as anti‐inflammatory, antimicrobial, and anticancer agents were evaluated. Furthermore, the toxicity of the synthesized compounds was studied and compared with the standard drugs, namely, diclofenac potassium and ibuprofen, using hemolysis assay. The results indicated that the ligands and the complex 9 possess superior anti‐inflammatory activities inhibiting albumin denaturation (89.88–100%) compared with the standard drugs (51.5–88.37%) at a concentration of 500 μg g^?1. These activities were related to the presence of the chelating N‐atoms in the ligands and the exchangeable chloro‐ groups in the complex. Moreover, the chloro‐ and thiophene groups in complex 9 produce a higher anticancer activity compared with its isothiocyanate derivative in the complex 11 and the 3,4‐dimethoxyphenyl moiety in complex 10 . Considering the toxicity results, the synthesized ligands are nontoxic or far less toxic compared with the standard drugs and the metal complexes. Therefore, these newly synthesized compounds are promising anti‐inflammatory agents in addition to their moderate unique broad antimicrobial activity.     

Duplex‐Selective Ruthenium‐Based DNA Intercalators

We report the design and synthesis of small molecules that exhibit enhanced luminescence in the presence of duplex rather than single‐stranded DNA. The local environment presented by a well‐known [Ru(dipyrido[3,2‐a:2′,3′‐c]phenazine)L₂]²⁺‐based DNA intercalator was modified by functionalizing the bipyridine ligands with esters and carboxylic acids. By systematically varying the number and charge of the pendant groups, it was determined that decreasing the electrostatic interaction between the intercalator and the anionic DNA backbone reduced single‐strand interactions and translated to better duplex specificity. In studying this class of complexes, a single Ru^II complex emerged that selectively luminesces in the presence of duplex DNA with little to no background from interacting with single‐stranded DNA. This complex shows promise as a new dye capable of selectively staining double‐ versus single‐stranded DNA in gel electrophoresis, which cannot be done with conventional SYBR dyes.     

Non‐iterative Asymmetric Synthesis of C15 Polyketide Spiroketals

The 2,2′‐methylenebis[furan] ( 1 ) was converted to 1‐{(4R,6S))‐6‐[(2R)‐2,4‐dihydroxybutyl]‐2,2‐dimethyl‐1,3‐dioxan‐4‐yl}‐3‐[(2R,4R)‐tetrahydro‐4,6‐dihydroxy‐2H‐pyran‐2‐yl)propan‐2‐one ((+)‐ 18 ) and its (4S)‐epimer (?)‐ 19 with high stereo‐ and enantioselectivity (Schemes 1–3). Under acidic methanolysis, (+)‐ 18 yielded a single spiroketal, (3R)‐4‐{(1R,3S,4′R,5R,6′S,7R)‐3′,4′,5′,6′‐tetrahydro‐4′‐hydroxy‐7‐methoxyspiro[2,6‐dioxabicyclo[3.3.1]nonane‐3,2′‐[2H]pyran]‐6′‐yl}butane‐1,3‐diol ((?)‐ 20 ), in which both O‐atoms at the spiro center reside in equatorial positions, this being due to the tricyclic nature of (?)‐ 20 (methyl pyranoside formation). Compound (?)‐ 19 was converted similarly into the (4′S)‐epimeric tricyclic spiroketal (?)‐ 21 that also adopts a similar (3S)‐configuration and conformation. Spiroketals (?)‐ 20 , (?)‐ 21 and analog (?)‐ 23 , i.e., (1R,3S,4′R,5R,6′R)‐3′,4′,5′,6′‐tetrahydro‐6′‐[(2S)‐2‐hydroxybut‐3‐enyl]‐7‐methoxyspiro[2,6‐dioxabicyclo[3.3.1]nonane‐3,2′‐[2H]pyran]‐4′‐ol, derived from (?)‐ 20 , were assayed for their cytotoxicity toward murine P388 lymphocytic leukemia and six human cancer cell lines. Only racemic (±)‐ 21 showed evidence of cancer‐cell‐growth inhibition (P388, ED₅₀: 6.9 μg/ml).